Fundz

Who to call at Orchestra BioMed Holdings, and when

Fundz watches for the moments Orchestra BioMed Holdings starts buying, and tells you who to reach.

  • An alert the day Orchestra BioMed Holdings raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Orchestra BioMed Holdings, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Orchestra BioMed Secures $15 Million Investment from Ligand as Part of Strategic Financing Agreement.

May 06, 2026

Contract Type

agreement

LondonManufacturingBiotechnologyHealth CareMedicalMedical Device

Description

Orchestra BioMed has announced a strategic financing agreement with Ligand for a $15 million investment. This funding aims to support the commercialization of their innovative medical technologies.

Company Information

Company

Orchestra BioMed Holdings

Location

London, England, United Kingdom

About

Orchestra BioMed Holdings, Inc. is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies. Its lead product candidate is atrioventricular interval modulation (AVIM) therapy for the treatment of hypertension, and it is also developing Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease.

Predictive Intelligence
Strategic

ML-powered predictions for Orchestra BioMed Holdings's next move

Learn about Strategic plan

Orchestra BioMed Holdings signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.